.OncoC4 is taking AcroImmune-- and its own internal scientific manufacturing capabilities-- under it...
.Amgen has shared (PDF) the initial phase 3 records on its own $400 thousand eczema medicine, linkin...
.Biogen and also UCB's bank on developing into stage 3 on the back of a failed research aims to have...
.Italian biotech Aptadir Therapeutics has actually released along with the promise that its own pipe...
.Surge Lifestyle Sciences has actually fulfilled its goal in a Duchenne muscle dystrophy (DMD) resea...
.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, taking up t...
.Achilles Rehabs has shreded its own strategy. The British biotech is knocking off on its clinical-p...
.Aligos Therapeutics is actually advertising a midstage gain in metabolic-dysfunction associated ste...
.Basilea Pharmaceutica's job creating new antifungals has received a substantial increase coming fro...
.Possessing presently gathered up the U.S. liberties to Capricor Therapies' late-stage Duchenne musc...